SCLC #NEWS: The @FDA approved a label update to the administration information for Amgen鈥檚 DLL3-targeting T-cell engager for certain patients with extensive-stage small cell lung cancer (ES-SCLC).
馃敆Learn more: amgen.ly/3TuDvIj
$AMGN
Amgen harnesses the best of biology and technology to fight the world鈥檚 toughest diseases.
馃敆 Guidelines: amgen.ly/RpcA3B

